Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study
- PMID: 26287484
- PMCID: PMC4545753
- DOI: 10.1371/journal.pone.0136368
Correction: Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study
Erratum for
-
Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.PLoS One. 2015 Jul 16;10(7):e0132514. doi: 10.1371/journal.pone.0132514. eCollection 2015. PLoS One. 2015. PMID: 26181578 Free PMC article.
References
-
- van Kampen SC, Tursynbayeva A, Koptleuova A, Murzabekova Z, Bigalieva L, Aubakirova M, et al. (2015) Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study. PLoS ONE 10(7): e0132514 doi: 10.1371/journal.pone.0132514 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
